SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences gets 2 new US patents

22 Sep 2010 Evaluate

Suven Life Sciences has received patents from the US for two new chemical entities (NCEs) used in treating disorders associated with the central nervous system. With the patents valid till 2022, the products of these inventions may be out-licensed at various phases of clinical trials.

 

The two patents include selective compounds discovered by Suven that are useful in treatment of disorders like Alzheimer’s disease, Parkinson, Schizophrenia and Attention Deficient Hyperactivity Disorder.The market for the cognitive disorders in the Central Nervous System arena has an estimated $ 30 billion market potential globally.

crackcrack

Suven Life Sciences Share Price

195.90 -0.10 (-0.05%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×